Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 2.52
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.16 | WT1 transcription factor |
|
MTF1
|
ENSG00000188786.10 | metal regulatory transcription factor 1 |
|
ZBTB7B
|
ENSG00000160685.13 | zinc finger and BTB domain containing 7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZBTB7B | hg38_v1_chr1_+_155002630_155002689 | -0.70 | 8.6e-06 | Click! |
| MTF1 | hg38_v1_chr1_-_37859583_37859609 | -0.57 | 7.0e-04 | Click! |
| WT1 | hg38_v1_chr11_-_32435360_32435419 | -0.09 | 6.2e-01 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 19.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 3.7 | 11.0 | GO:0036304 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 3.6 | 32.1 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.4 | 27.6 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 3.4 | 3.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 3.4 | 13.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 3.3 | 13.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 3.3 | 6.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 3.2 | 9.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 3.0 | 9.1 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 3.0 | 3.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 3.0 | 15.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 2.9 | 11.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 2.8 | 2.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 2.7 | 5.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 2.7 | 19.0 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 2.7 | 2.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 2.7 | 8.0 | GO:0097187 | dentinogenesis(GO:0097187) |
| 2.7 | 8.0 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.6 | 7.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 2.5 | 5.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 2.5 | 7.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 2.3 | 9.4 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 2.3 | 7.0 | GO:1905033 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 2.3 | 7.0 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 2.3 | 6.9 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.3 | 6.8 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 2.3 | 11.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 2.3 | 6.8 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 2.2 | 2.2 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 2.2 | 17.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 2.2 | 15.3 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 2.2 | 8.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 2.2 | 6.5 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 2.1 | 15.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 2.1 | 59.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 2.1 | 4.2 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
| 2.0 | 2.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
| 2.0 | 6.0 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 2.0 | 11.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.0 | 9.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 1.9 | 25.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.9 | 7.8 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 1.9 | 9.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 1.9 | 5.7 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
| 1.9 | 11.5 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.9 | 7.6 | GO:1905069 | allantois development(GO:1905069) |
| 1.9 | 11.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.9 | 5.6 | GO:0051463 | negative regulation of cortisol secretion(GO:0051463) |
| 1.9 | 5.6 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 1.9 | 5.6 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 1.9 | 11.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.8 | 25.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.8 | 10.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.8 | 12.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 1.8 | 37.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 1.8 | 5.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.8 | 32.4 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 1.8 | 24.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.8 | 14.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.7 | 7.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.7 | 5.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.7 | 1.7 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) plasma membrane long-chain fatty acid transport(GO:0015911) |
| 1.7 | 5.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 1.7 | 13.8 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.7 | 6.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.7 | 1.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.7 | 5.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.7 | 3.4 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
| 1.7 | 1.7 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
| 1.7 | 32.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 1.7 | 13.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.7 | 5.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.7 | 6.7 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.7 | 6.6 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 1.6 | 4.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.6 | 6.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 1.6 | 11.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 1.6 | 4.8 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 1.6 | 6.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.6 | 1.6 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 1.5 | 6.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 1.5 | 4.6 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.5 | 13.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.5 | 4.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.5 | 4.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.5 | 5.9 | GO:0035498 | carnosine metabolic process(GO:0035498) |
| 1.5 | 8.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 1.5 | 4.4 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 1.4 | 5.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.4 | 10.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.4 | 1.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 1.4 | 14.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 1.4 | 16.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.4 | 12.6 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 1.4 | 12.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 1.4 | 5.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 1.4 | 6.8 | GO:0033197 | response to vitamin E(GO:0033197) |
| 1.3 | 4.0 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.3 | 1.3 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 1.3 | 17.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.3 | 13.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.3 | 3.9 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.3 | 18.4 | GO:0046958 | nonassociative learning(GO:0046958) |
| 1.3 | 3.9 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 1.3 | 3.9 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.3 | 16.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.3 | 3.9 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 1.3 | 11.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.3 | 5.2 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.3 | 2.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.3 | 7.7 | GO:0035607 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
| 1.3 | 25.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.3 | 5.1 | GO:1903627 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 1.3 | 20.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.3 | 13.8 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.2 | 8.7 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.2 | 2.5 | GO:1903937 | response to acrylamide(GO:1903937) |
| 1.2 | 13.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 1.2 | 7.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.2 | 3.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 1.2 | 23.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.2 | 1.2 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.2 | 6.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 1.2 | 3.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.2 | 19.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 1.2 | 9.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.2 | 3.6 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.2 | 5.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 1.2 | 1.2 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.2 | 7.1 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.2 | 3.5 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 1.2 | 19.7 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.2 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.2 | 6.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 1.1 | 3.4 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.1 | 10.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.1 | 11.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 1.1 | 67.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.1 | 4.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 1.1 | 9.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.1 | 2.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 1.1 | 10.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.1 | 1.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.1 | 15.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.1 | 7.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.1 | 3.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.1 | 5.5 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.1 | 12.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.1 | 13.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.1 | 3.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 1.1 | 3.2 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.1 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 1.1 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 1.1 | 16.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 1.1 | 4.3 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 | 4.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 1.1 | 3.2 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 1.1 | 10.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 1.1 | 3.2 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.0 | 5.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 1.0 | 6.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 1.0 | 1.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.0 | 4.1 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.0 | 1.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 1.0 | 8.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.0 | 4.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 1.0 | 16.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.0 | 14.1 | GO:0009414 | response to water deprivation(GO:0009414) |
| 1.0 | 5.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.0 | 3.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.0 | 7.9 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.0 | 4.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.0 | 2.0 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 1.0 | 13.8 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 1.0 | 5.9 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.0 | 4.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.0 | 1.9 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.0 | 3.9 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.0 | 3.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 1.0 | 3.8 | GO:0060596 | mammary placode formation(GO:0060596) |
| 1.0 | 8.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.0 | 2.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) operant conditioning(GO:0035106) |
| 1.0 | 4.8 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 1.0 | 3.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.0 | 2.9 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.9 | 4.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.9 | 0.9 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
| 0.9 | 5.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.9 | 2.8 | GO:0032328 | alanine transport(GO:0032328) |
| 0.9 | 12.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.9 | 62.5 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.9 | 0.9 | GO:0035922 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.9 | 0.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.9 | 5.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.9 | 17.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.9 | 9.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.9 | 12.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.9 | 6.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.9 | 4.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.9 | 2.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.9 | 2.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.9 | 3.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.9 | 5.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.9 | 2.7 | GO:2000485 | regulation of glutamine transport(GO:2000485) |
| 0.9 | 5.4 | GO:0015853 | adenine transport(GO:0015853) |
| 0.9 | 0.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.9 | 12.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.9 | 9.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.9 | 4.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.9 | 3.6 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.9 | 6.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.9 | 3.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.9 | 4.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.9 | 8.8 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.9 | 0.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.9 | 3.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.9 | 0.9 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.9 | 5.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.9 | 1.7 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.9 | 3.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.9 | 6.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.8 | 2.5 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 0.8 | 3.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.8 | 12.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.8 | 3.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.8 | 5.9 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.8 | 3.4 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.8 | 18.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.8 | 2.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.8 | 1.7 | GO:0035377 | transepithelial water transport(GO:0035377) |
| 0.8 | 2.5 | GO:0061699 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.8 | 8.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.8 | 7.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.8 | 1.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.8 | 2.5 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.8 | 6.5 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.8 | 2.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 | 4.0 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.8 | 4.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.8 | 1.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.8 | 7.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.8 | 4.0 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.8 | 2.4 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.8 | 9.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.8 | 4.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.8 | 5.5 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.8 | 3.1 | GO:2000724 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.8 | 1.6 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.8 | 20.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.8 | 3.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.8 | 3.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.8 | 6.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.8 | 1.5 | GO:0014028 | notochord formation(GO:0014028) |
| 0.8 | 2.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.8 | 1.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.8 | 3.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 | 5.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.8 | 0.8 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.8 | 9.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.7 | 5.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.7 | 3.0 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.7 | 0.7 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.7 | 1.5 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.7 | 0.7 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.7 | 0.7 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 2.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 | 7.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.7 | 9.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.7 | 7.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.7 | 6.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.7 | 5.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.7 | 3.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.7 | 7.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.7 | 3.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.7 | 2.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.7 | 7.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.7 | 7.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 | 2.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.7 | 2.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.7 | 3.5 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.7 | 3.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.7 | 0.7 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 0.7 | 6.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.7 | 9.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.7 | 6.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.7 | 0.7 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.7 | 2.8 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 | 4.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.7 | 2.1 | GO:0001970 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of activation of membrane attack complex(GO:0001970) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.7 | 2.1 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
| 0.7 | 1.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.7 | 4.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.7 | 2.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.7 | 3.4 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.7 | 1.3 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 | 1.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.7 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.7 | 1.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.7 | 4.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 | 7.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.7 | 1.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.7 | 5.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.7 | 2.0 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.6 | 1.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.6 | 2.6 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.6 | 0.6 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.6 | 3.2 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.6 | 16.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.6 | 1.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.6 | 1.9 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.6 | 7.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.6 | 1.3 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) dGDP metabolic process(GO:0046066) |
| 0.6 | 30.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.6 | 2.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.6 | 5.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.6 | 1.9 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.6 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.6 | 3.8 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.6 | 1.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.6 | 1.9 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.6 | 2.5 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.6 | 1.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.6 | 3.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.6 | 2.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.6 | 4.3 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.6 | 13.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.6 | 12.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.6 | 3.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.6 | 2.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.6 | 2.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.6 | 12.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.6 | 1.8 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.6 | 0.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.6 | 1.2 | GO:1990172 | G-protein coupled receptor catabolic process(GO:1990172) |
| 0.6 | 3.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.6 | 12.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.6 | 13.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.6 | 2.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.6 | 1.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.6 | 1.8 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.6 | 7.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.6 | 1.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.6 | 17.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.6 | 1.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.6 | 8.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.6 | 5.9 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.6 | 4.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.6 | 4.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.6 | 2.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.6 | 2.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.6 | 3.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.6 | 1.7 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
| 0.6 | 9.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.6 | 8.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.6 | 4.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.6 | 1.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.6 | 2.9 | GO:0033504 | floor plate development(GO:0033504) |
| 0.6 | 7.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.6 | 1.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.6 | 1.7 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 0.6 | 4.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.6 | 3.4 | GO:0043084 | penile erection(GO:0043084) |
| 0.6 | 4.0 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.6 | 4.0 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 4.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.6 | 10.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.6 | 4.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.6 | 12.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.6 | 2.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.6 | 6.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.6 | 10.0 | GO:0035878 | nail development(GO:0035878) |
| 0.6 | 0.6 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.6 | 1.1 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.6 | 1.7 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.6 | 2.2 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.6 | 7.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.6 | 2.8 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.6 | 1.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.6 | 2.2 | GO:0048749 | compound eye development(GO:0048749) |
| 0.6 | 2.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.5 | 1.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.5 | 15.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.5 | 1.6 | GO:0070778 | malate-aspartate shuttle(GO:0043490) L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.5 | 2.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.5 | 2.2 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.5 | 6.6 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.5 | 2.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.5 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
| 0.5 | 14.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.5 | 9.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.5 | 11.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 2.1 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.5 | 6.9 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.5 | 1.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.5 | 6.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 | 9.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.5 | 10.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 4.7 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.5 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.5 | 1.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.5 | 5.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.5 | 3.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.5 | 0.5 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 0.5 | 3.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 3.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 | 3.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 | 2.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.5 | 1.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.5 | 3.0 | GO:0007497 | posterior midgut development(GO:0007497) |
| 0.5 | 2.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.5 | 8.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.5 | 22.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 | 22.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.5 | 15.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.5 | 6.5 | GO:0060068 | vagina development(GO:0060068) |
| 0.5 | 1.0 | GO:0006538 | glutamate biosynthetic process(GO:0006537) glutamate catabolic process(GO:0006538) |
| 0.5 | 3.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.5 | 1.5 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.5 | 2.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.5 | 7.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.5 | 5.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 6.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 | 4.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.5 | 2.5 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.5 | 3.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.5 | 6.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 | 9.8 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.5 | 2.9 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.5 | 4.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.5 | 3.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.5 | 0.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.5 | 1.5 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
| 0.5 | 4.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.5 | 4.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.5 | 5.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 | 1.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.5 | 8.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 | 12.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.5 | 1.0 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 | 1.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.5 | 1.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.5 | 0.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.5 | 17.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.5 | 11.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.5 | 1.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.5 | 1.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 | 10.8 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.5 | 1.4 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.5 | 1.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 9.8 | GO:0048265 | response to pain(GO:0048265) |
| 0.5 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.5 | 1.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 | 2.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 | 2.8 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 1.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.5 | 2.8 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.5 | 0.9 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.5 | 10.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.5 | 0.9 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.5 | 0.5 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.5 | 2.3 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.5 | 5.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.5 | 4.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.5 | 0.5 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.5 | 13.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.5 | 4.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.5 | 2.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.5 | 9.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.5 | 0.9 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.5 | 10.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.5 | 2.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.5 | 1.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.5 | 0.9 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.5 | 5.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.5 | 1.8 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.5 | 1.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.5 | 3.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.4 | 8.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 0.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.4 | 2.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.4 | 0.4 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.4 | 6.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.4 | 0.4 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
| 0.4 | 8.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 9.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.4 | 1.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.4 | 7.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.4 | 2.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.4 | 23.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.4 | 14.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 | 1.3 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 0.4 | 2.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.4 | 4.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.4 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.4 | 0.4 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
| 0.4 | 2.6 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.4 | 1.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 | 4.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.4 | 0.4 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 | 8.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.4 | 2.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.4 | 1.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.4 | 1.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 | 1.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.4 | 2.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.4 | 1.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.4 | 1.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.4 | 0.9 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 14.0 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.4 | 3.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.4 | 7.2 | GO:0009650 | UV protection(GO:0009650) |
| 0.4 | 3.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.4 | 2.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.4 | 3.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.4 | 1.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.4 | 4.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.4 | 5.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 | 2.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 | 1.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.4 | 7.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.4 | 2.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.4 | 3.7 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.4 | 4.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 2.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.4 | 0.4 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.4 | 11.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.4 | 2.5 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.4 | 1.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.4 | 10.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.4 | 2.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.4 | 1.2 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.4 | 0.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.4 | 3.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.4 | 2.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.4 | 6.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.4 | 1.2 | GO:0018011 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 0.4 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.4 | 2.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
| 0.4 | 18.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.4 | 1.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.4 | 3.9 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.4 | 8.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.4 | 1.9 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.4 | 1.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.4 | 1.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.4 | 5.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.4 | 1.5 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.4 | 1.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.4 | 7.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.4 | 2.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 | 0.8 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.4 | 0.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.4 | 25.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.4 | 3.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.4 | 1.1 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.4 | 1.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.4 | 8.6 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 | 0.7 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.4 | 8.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.4 | 5.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 7.7 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.4 | 2.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.4 | 1.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 2.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.4 | 9.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.4 | 3.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.4 | 1.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 1.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.4 | 3.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 5.7 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.4 | 3.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.4 | 3.9 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.4 | 7.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 3.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 4.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 1.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 0.4 | 1.1 | GO:0051041 | positive regulation of calcium-independent cell-cell adhesion(GO:0051041) |
| 0.4 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 6.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 4.2 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
| 0.4 | 11.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 | 2.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.3 | 1.0 | GO:1904864 | regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 0.3 | 0.7 | GO:0071462 | positive regulation of anagen(GO:0051885) cellular response to water stimulus(GO:0071462) cellular response to hydrostatic pressure(GO:0071464) |
| 0.3 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.3 | 1.7 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 | 0.7 | GO:1903802 | L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.3 | 7.6 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.3 | 1.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 4.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.3 | 1.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.3 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 2.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 0.3 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.3 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 3.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.3 | 1.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 2.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 | 18.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.3 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.3 | 2.0 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.3 | 1.0 | GO:2000559 | CD24 biosynthetic process(GO:0035724) activation of meiosis involved in egg activation(GO:0060466) activation of meiosis(GO:0090427) negative regulation of monocyte extravasation(GO:2000438) regulation of CD24 biosynthetic process(GO:2000559) positive regulation of CD24 biosynthetic process(GO:2000560) |
| 0.3 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.3 | 0.3 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 | 1.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.3 | 2.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.3 | 5.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.3 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.3 | 1.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.3 | 1.0 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 | 6.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.3 | 0.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.3 | 0.3 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.3 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.3 | 4.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 9.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.3 | 6.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.3 | 2.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 0.6 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 0.3 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.3 | 0.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.3 | 1.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.3 | 10.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.3 | 2.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.3 | 4.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.3 | 1.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.3 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 1.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.3 | 1.2 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.3 | 2.2 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.3 | 0.9 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.3 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.3 | 0.9 | GO:0021794 | thalamus development(GO:0021794) |
| 0.3 | 1.5 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.3 | 2.4 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.3 | 4.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 1.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 6.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.3 | 0.9 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 | 1.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.3 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 | 3.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.3 | 1.5 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.3 | 0.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.3 | 1.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 9.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 | 5.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 1.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.3 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.3 | 0.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 | 1.2 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.3 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 | 1.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 | 1.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 | 7.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.3 | 12.7 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.3 | 0.9 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.3 | 2.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.3 | 1.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.3 | 30.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.3 | 2.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.3 | 5.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 1.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 5.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 6.6 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 3.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.3 | 2.5 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.3 | 0.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.3 | 0.3 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
| 0.3 | 3.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.3 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.3 | 0.5 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
| 0.3 | 1.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 5.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.3 | 0.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.3 | 1.1 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.3 | 0.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 | 1.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.3 | 0.8 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.3 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 | 2.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 | 6.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.3 | 6.4 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
| 0.3 | 1.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.3 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 7.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.3 | 0.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.3 | 2.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 3.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.3 | 0.8 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.3 | 1.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.3 | 2.6 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 | 1.8 | GO:0007567 | parturition(GO:0007567) |
| 0.3 | 13.2 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
| 0.3 | 9.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.3 | 0.8 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 3.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.3 | 0.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.3 | 2.3 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.3 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.3 | 4.8 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.3 | 0.8 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.3 | 2.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.3 | 0.8 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.3 | 9.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 | 0.8 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.3 | 21.6 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.3 | 0.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 | 0.8 | GO:0030683 | evasion or tolerance of host immune response(GO:0020012) evasion or tolerance of host defense response(GO:0030682) evasion or tolerance by virus of host immune response(GO:0030683) evasion or tolerance of immune response of other organism involved in symbiotic interaction(GO:0051805) evasion or tolerance of defense response of other organism involved in symbiotic interaction(GO:0051807) |
| 0.2 | 0.5 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 2.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 | 1.5 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 | 0.2 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 7.2 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 1.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 | 1.7 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.2 | 0.7 | GO:0048670 | regulation of collateral sprouting(GO:0048670) positive regulation of collateral sprouting(GO:0048672) |
| 0.2 | 4.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 1.0 | GO:0097286 | iron ion import(GO:0097286) |
| 0.2 | 7.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.2 | 1.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 1.0 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.2 | 0.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 | 1.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 | 6.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 | 0.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 | 12.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.2 | 3.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 1.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 1.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 2.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 | 2.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.2 | 2.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 | 1.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 | 2.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.7 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 1.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.2 | 0.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.2 | 10.3 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.2 | 0.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.2 | 2.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.2 | 1.6 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.2 | 14.9 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.2 | 1.4 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.2 | 0.9 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.2 | 1.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.2 | 2.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 | 2.0 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 2.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 39.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 0.7 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 | 1.3 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.2 | 0.4 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 7.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 | 2.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 0.7 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.2 | 1.1 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.2 | 3.3 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.2 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.4 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 25.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 2.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.2 | 2.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.2 | 4.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 1.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.2 | 0.2 | GO:0046113 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) uracil catabolic process(GO:0006212) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) nucleobase catabolic process(GO:0046113) |
| 0.2 | 6.1 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 | 1.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 | 0.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.2 | 0.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 | 7.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.2 | 7.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 2.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.2 | 6.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 2.7 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
| 0.2 | 2.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.2 | 1.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.2 | 2.3 | GO:1902001 | carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
| 0.2 | 5.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 | 0.8 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.2 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 3.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 1.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.2 | 3.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.2 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 7.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.2 | 1.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.2 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.2 | 0.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 | 3.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 2.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 | 2.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.2 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.2 | 0.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 | 0.6 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.2 | 1.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.2 | 5.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.2 | 0.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.2 | 5.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.2 | 7.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.2 | 6.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 1.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 5.0 | GO:0008542 | visual learning(GO:0008542) |
| 0.2 | 0.7 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.2 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 2.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 4.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 | 7.7 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 0.5 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.2 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 1.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 | 2.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 3.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.2 | 1.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 2.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 0.2 | GO:0060841 | venous blood vessel development(GO:0060841) |
| 0.2 | 0.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.2 | 5.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 0.9 | GO:1902460 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.2 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 | 2.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.2 | 1.4 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.2 | 2.5 | GO:0003341 | cilium movement(GO:0003341) |
| 0.2 | 1.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 13.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.2 | 0.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 | 16.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.2 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.2 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.2 | 1.9 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) |
| 0.2 | 0.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.2 | 0.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 0.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 0.2 | 1.4 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.2 | 0.2 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 1.9 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.2 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 0.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 | 1.0 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.2 | 3.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 0.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.2 | 1.0 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 | 1.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.2 | 0.5 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.2 | 1.9 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.2 | 1.3 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
| 0.2 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.2 | 0.3 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 0.2 | 1.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 | 1.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 0.5 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.2 | 0.2 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.2 | 0.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 2.9 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.8 | GO:0009415 | response to water(GO:0009415) |
| 0.2 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 3.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.2 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.2 | 10.4 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.2 | 0.3 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 | 0.3 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 | 0.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 2.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.2 | 1.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 | 0.2 | GO:0097536 | thymus epithelium morphogenesis(GO:0097536) |
| 0.2 | 10.3 | GO:0008652 | cellular amino acid biosynthetic process(GO:0008652) |
| 0.2 | 0.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 | 0.3 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.1 | 0.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 7.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 2.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 3.4 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 | 2.8 | GO:0043090 | amino acid import(GO:0043090) |
| 0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.7 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 1.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 2.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 1.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.1 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 | 2.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 | 2.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 2.0 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 | 1.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 2.9 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.1 | 12.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 1.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.1 | 0.8 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 1.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 | 2.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 0.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.1 | 0.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 6.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.1 | 1.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 2.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.1 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 2.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 | 0.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.3 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 1.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 1.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 0.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 2.6 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 | 0.7 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
| 0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 | 2.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 20.2 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.1 | 2.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.5 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.1 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.1 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.1 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 0.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.3 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 3.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 0.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 | 6.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 1.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 1.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.4 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 | 0.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.1 | 0.4 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 1.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.5 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.1 | 1.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.1 | 1.5 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 0.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 9.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 1.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.1 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 1.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.4 | GO:0061744 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.4 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.1 | 0.5 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.5 | GO:0071871 | response to epinephrine(GO:0071871) |
| 0.1 | 1.7 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
| 0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
| 0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.1 | 0.3 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 | 0.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 0.2 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 2.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
| 0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 5.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 0.7 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 | 0.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
| 0.1 | 1.1 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 1.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 3.5 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.2 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
| 0.1 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 1.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 1.7 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 1.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.1 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.2 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.1 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.6 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.3 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.1 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.5 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 1.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.2 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 | 0.1 | GO:0010041 | response to iron(III) ion(GO:0010041) |
| 0.1 | 0.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.4 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
| 0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.6 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 | 0.1 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.2 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.1 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.1 | 1.5 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.1 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
| 0.1 | 0.2 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.1 | 3.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.2 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 1.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 0.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 1.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.0 | 6.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.0 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.0 | 1.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.0 | 0.6 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 4.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.0 | 0.3 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.0 | 0.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 | 0.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.0 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 | 1.1 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.0 | 0.4 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 | 1.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.0 | 0.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 | 0.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.0 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.0 | 0.2 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.0 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 1.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 0.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 | 0.1 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.0 | 4.0 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.5 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.0 | 0.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.1 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.0 | 0.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.0 | 1.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.2 | GO:0006821 | chloride transport(GO:0006821) |
| 0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.0 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
| 0.0 | 0.1 | GO:0036303 | lymph vessel morphogenesis(GO:0036303) |
| 0.0 | 2.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.7 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.0 | 0.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.0 | 3.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.1 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.0 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 | 0.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 | 0.0 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.0 | 0.0 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:0006813 | potassium ion transport(GO:0006813) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.7 | 53.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 3.9 | 19.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.7 | 18.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 3.5 | 28.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 2.8 | 8.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.8 | 11.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 2.4 | 9.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 2.3 | 6.8 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 2.2 | 6.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 2.2 | 11.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 2.2 | 8.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 2.1 | 6.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 2.0 | 18.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 2.0 | 9.8 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.9 | 19.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.9 | 7.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.7 | 8.5 | GO:0016938 | kinesin I complex(GO:0016938) |
| 1.7 | 5.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.6 | 11.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 1.5 | 4.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.5 | 4.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 1.5 | 9.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 1.5 | 4.5 | GO:1990742 | microvesicle(GO:1990742) |
| 1.5 | 4.4 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 1.4 | 14.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.3 | 1.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.3 | 1.3 | GO:0044301 | climbing fiber(GO:0044301) |
| 1.2 | 8.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 1.2 | 49.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 1.2 | 6.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.2 | 54.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 1.2 | 9.7 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.2 | 22.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 1.2 | 18.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 1.1 | 16.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 1.1 | 8.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 1.1 | 21.3 | GO:0031045 | dense core granule(GO:0031045) |
| 1.1 | 3.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.1 | 5.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 1.0 | 2.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.0 | 3.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.0 | 5.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.0 | 9.1 | GO:0031673 | H zone(GO:0031673) |
| 1.0 | 3.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.0 | 5.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 1.0 | 2.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.0 | 6.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.9 | 19.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 24.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.9 | 26.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.9 | 23.6 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.9 | 4.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.9 | 38.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.9 | 9.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.8 | 8.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.8 | 19.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.8 | 2.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.8 | 1.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.8 | 35.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.8 | 4.0 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.8 | 13.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.8 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.8 | 9.2 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.8 | 6.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.8 | 3.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.8 | 28.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.7 | 14.2 | GO:0008091 | spectrin(GO:0008091) |
| 0.7 | 11.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.7 | 7.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.7 | 4.4 | GO:0044393 | microspike(GO:0044393) |
| 0.7 | 2.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.7 | 5.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.7 | 3.6 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.7 | 15.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.7 | 80.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.7 | 4.9 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.7 | 3.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.7 | 2.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.7 | 15.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.7 | 4.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.7 | 4.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.6 | 3.9 | GO:0032449 | CBM complex(GO:0032449) |
| 0.6 | 12.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.6 | 33.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.6 | 8.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.6 | 4.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.6 | 8.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.6 | 14.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 15.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.6 | 2.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.6 | 3.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.6 | 8.5 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.6 | 27.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.6 | 2.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.6 | 3.4 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.6 | 1.7 | GO:0005914 | spot adherens junction(GO:0005914) |
| 0.6 | 1.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 0.6 | 12.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 4.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.5 | 4.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.5 | 0.5 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.5 | 1.6 | GO:0030849 | autosome(GO:0030849) |
| 0.5 | 7.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.5 | 8.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.5 | 2.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.5 | 93.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.5 | 15.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.5 | 18.0 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.5 | 2.5 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.5 | 3.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.5 | 8.1 | GO:0043203 | axon hillock(GO:0043203) |
| 0.5 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.5 | 2.5 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 1.0 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.5 | 17.9 | GO:0032589 | neuron projection membrane(GO:0032589) |
| 0.5 | 3.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.5 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.5 | 1.9 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.5 | 6.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.5 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.5 | 195.2 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.5 | 8.9 | GO:0045180 | basal cortex(GO:0045180) |
| 0.5 | 6.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.5 | 65.4 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.5 | 8.7 | GO:0042627 | chylomicron(GO:0042627) |
| 0.5 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.5 | 1.8 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.4 | 2.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.4 | 20.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.4 | 7.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.4 | 21.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.4 | 3.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.4 | 2.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.4 | 5.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.4 | 13.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.4 | 15.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 32.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.4 | 3.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 33.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.4 | 50.1 | GO:0043204 | perikaryon(GO:0043204) |
| 0.4 | 35.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.4 | 11.0 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 0.8 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.4 | 2.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 4.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.4 | 2.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 1.1 | GO:0044308 | axonal spine(GO:0044308) |
| 0.4 | 2.5 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 42.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 2.8 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 145.4 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.3 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 12.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.3 | 8.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.3 | 4.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.3 | 1.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.3 | 37.4 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 2.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.3 | 5.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.3 | 3.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.3 | 6.4 | GO:0002102 | podosome(GO:0002102) |
| 0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 10.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.3 | 0.9 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.3 | 2.2 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 4.4 | GO:0097433 | dense body(GO:0097433) |
| 0.3 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.3 | 40.6 | GO:0005604 | basement membrane(GO:0005604) |
| 0.3 | 12.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.3 | 2.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 4.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.3 | 1.5 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.3 | 0.9 | GO:0001534 | radial spoke(GO:0001534) |
| 0.3 | 50.2 | GO:0098793 | presynapse(GO:0098793) |
| 0.3 | 4.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.3 | 3.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 0.9 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.3 | 0.9 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.3 | 30.6 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.3 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.3 | 6.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.3 | 1.1 | GO:0071920 | cleavage body(GO:0071920) |
| 0.3 | 1.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.3 | 3.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.3 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.3 | 7.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.3 | 2.7 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 3.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.3 | 1.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.3 | 1.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 0.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 1.7 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 1.0 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.2 | 0.5 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 3.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 12.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 0.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 27.4 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.2 | 4.8 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.2 | 1.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 69.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.2 | 48.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 7.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 1.3 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 1.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 2.6 | GO:0070449 | elongin complex(GO:0070449) |
| 0.2 | 2.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.2 | 0.6 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.2 | 0.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.2 | 10.5 | GO:0044309 | neuron spine(GO:0044309) |
| 0.2 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 13.6 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 8.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 24.8 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 4.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.2 | 3.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 4.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.9 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 39.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.2 | 4.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 2.4 | GO:0044448 | cell cortex part(GO:0044448) |
| 0.2 | 6.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 1.1 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 3.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 0.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 13.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 2.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 5.8 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.2 | 37.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.2 | 0.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.2 | 1.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 30.3 | GO:0030424 | axon(GO:0030424) |
| 0.2 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 9.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 2.0 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.2 | 2.5 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 0.8 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 3.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.2 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.2 | 19.9 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.2 | 2.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 2.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 3.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.2 | 0.8 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
| 0.2 | 32.0 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.2 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 6.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 2.5 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 1.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 2.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
| 0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 3.2 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 4.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 4.9 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 18.0 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 1.7 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.4 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 9.9 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.3 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 27.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.1 | 0.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 1.0 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 10.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 3.8 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 6.8 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.1 | 10.9 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.1 | 2.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 5.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 23.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 1.1 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 28.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 1.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 0.2 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 3.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 2.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 0.8 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 3.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 1.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.1 | 62.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.1 | 5.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.1 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.1 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 51.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.1 | 6.0 | GO:0005938 | cell cortex(GO:0005938) |
| 0.1 | 8.2 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.3 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.1 | 0.5 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 1.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 81.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.1 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 199.0 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 50.4 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.0 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.2 | GO:0035101 | FACT complex(GO:0035101) |
| 0.0 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 0.3 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 9.8 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 3.4 | GO:0031984 | organelle subcompartment(GO:0031984) |
| 0.0 | 3.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.5 | 27.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 3.3 | 19.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 3.2 | 12.8 | GO:0035939 | microsatellite binding(GO:0035939) |
| 3.2 | 12.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 3.0 | 15.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 2.9 | 2.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 2.9 | 8.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 2.9 | 17.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 2.8 | 2.8 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 2.7 | 19.0 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 2.7 | 13.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 2.6 | 7.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 2.5 | 38.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 2.5 | 12.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 2.5 | 15.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 2.5 | 9.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.5 | 12.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 2.4 | 9.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 2.3 | 7.0 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 2.3 | 6.9 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 2.3 | 18.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 2.2 | 8.7 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 2.0 | 7.9 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 1.9 | 9.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.9 | 11.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.9 | 5.6 | GO:0036332 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
| 1.8 | 9.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 1.8 | 8.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.8 | 26.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.7 | 12.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 1.7 | 6.8 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.7 | 6.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.7 | 5.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.7 | 16.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.7 | 8.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.6 | 4.8 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.6 | 12.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.6 | 4.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.6 | 4.7 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 1.5 | 7.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.5 | 4.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 1.4 | 4.3 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.4 | 4.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 1.4 | 5.7 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 1.4 | 11.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.4 | 12.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 1.4 | 5.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.4 | 28.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.4 | 36.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 1.4 | 12.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.4 | 13.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 1.4 | 5.5 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 1.4 | 4.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 1.3 | 5.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.3 | 79.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 1.3 | 8.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 1.3 | 4.0 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 1.3 | 5.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 1.3 | 7.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.3 | 5.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.3 | 8.9 | GO:0097001 | ceramide binding(GO:0097001) |
| 1.3 | 1.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 1.3 | 16.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.3 | 7.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 1.3 | 5.1 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 1.3 | 2.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 1.3 | 5.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.2 | 7.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.2 | 8.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 1.2 | 16.6 | GO:0036122 | BMP binding(GO:0036122) |
| 1.2 | 4.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.2 | 2.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.2 | 7.1 | GO:0052846 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.2 | 5.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 1.2 | 38.1 | GO:0031005 | filamin binding(GO:0031005) |
| 1.2 | 5.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 1.1 | 2.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) L-asparagine transmembrane transporter activity(GO:0015182) |
| 1.1 | 3.4 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 1.1 | 19.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.1 | 3.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 1.1 | 36.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
| 1.1 | 3.4 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 1.1 | 4.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.1 | 4.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.1 | 4.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.1 | 3.4 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 1.1 | 3.4 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 1.1 | 4.5 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.1 | 15.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.1 | 13.1 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.1 | 3.3 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.1 | 3.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 1.1 | 5.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 1.1 | 4.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 1.1 | 6.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 1.1 | 4.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 1.1 | 10.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.1 | 6.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.1 | 3.2 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 1.0 | 16.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 1.0 | 2.1 | GO:0035276 | ethanol binding(GO:0035276) |
| 1.0 | 9.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.0 | 6.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 1.0 | 3.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.0 | 11.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.0 | 6.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.0 | 2.9 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 1.0 | 4.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.0 | 2.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.0 | 2.9 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 1.0 | 1.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 1.0 | 17.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 1.0 | 2.9 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.9 | 6.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.9 | 10.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.9 | 3.8 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.9 | 3.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.9 | 0.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.9 | 26.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.9 | 3.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.9 | 13.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.9 | 5.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.9 | 14.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.9 | 3.6 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.9 | 3.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.9 | 17.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.9 | 3.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.9 | 2.6 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.9 | 7.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.9 | 7.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.8 | 3.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.8 | 8.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.8 | 2.5 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 0.8 | 2.5 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.8 | 8.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.8 | 5.7 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.8 | 6.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.8 | 10.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.8 | 3.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.8 | 4.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.8 | 4.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 11.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.8 | 5.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.8 | 1.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.7 | 2.2 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.7 | 3.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.7 | 7.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.7 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.7 | 2.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.7 | 14.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.7 | 2.2 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.7 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.7 | 2.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.7 | 13.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.7 | 11.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.7 | 4.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.7 | 0.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.7 | 10.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.7 | 7.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.7 | 3.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.7 | 16.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.7 | 2.1 | GO:0038100 | nodal binding(GO:0038100) |
| 0.7 | 0.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.7 | 1.4 | GO:0051379 | epinephrine binding(GO:0051379) |
| 0.7 | 2.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
| 0.7 | 7.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.7 | 3.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.7 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.7 | 6.7 | GO:0042835 | BRE binding(GO:0042835) |
| 0.7 | 6.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.7 | 2.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.7 | 2.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.7 | 6.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.7 | 2.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.7 | 5.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.7 | 2.0 | GO:0019785 | ISG15-specific protease activity(GO:0019785) |
| 0.7 | 18.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.7 | 27.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.7 | 23.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.7 | 2.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.7 | 2.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.6 | 2.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.6 | 23.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.6 | 7.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.6 | 1.9 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.6 | 3.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 3.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.6 | 3.8 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.6 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.6 | 3.1 | GO:0070404 | NADH binding(GO:0070404) |
| 0.6 | 16.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.6 | 20.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.6 | 2.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.6 | 1.8 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.6 | 3.1 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.6 | 11.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.6 | 3.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.6 | 2.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.6 | 1.8 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.6 | 1.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.6 | 6.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.6 | 14.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.6 | 16.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.6 | 3.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.6 | 14.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.6 | 4.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.6 | 5.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.6 | 3.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.6 | 2.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.6 | 13.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.6 | 9.6 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.6 | 12.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.6 | 2.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.6 | 6.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.6 | 3.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.6 | 1.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.6 | 3.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.6 | 2.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.6 | 1.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.6 | 3.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.5 | 4.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.5 | 8.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.5 | 16.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.5 | 1.6 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.5 | 11.8 | GO:0019841 | retinol binding(GO:0019841) |
| 0.5 | 2.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.5 | 0.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.5 | 1.6 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.5 | 35.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.5 | 10.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.5 | 1.6 | GO:0061599 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.5 | 1.6 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.5 | 2.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.5 | 34.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.5 | 2.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.5 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.5 | 1.5 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.5 | 10.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.5 | 4.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.5 | 7.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.5 | 5.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.5 | 7.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 1.5 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.5 | 2.5 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.5 | 15.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.5 | 7.8 | GO:0015250 | water channel activity(GO:0015250) |
| 0.5 | 4.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.5 | 3.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.5 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 2.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.5 | 1.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.5 | 1.5 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.5 | 8.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.5 | 9.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.5 | 9.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 2.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.5 | 1.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.5 | 3.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.5 | 1.9 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.5 | 9.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.5 | 2.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.5 | 4.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 11.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.5 | 2.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.5 | 1.9 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.5 | 5.6 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.5 | 10.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 9.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.5 | 9.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.4 | 2.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.4 | 4.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 1.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.4 | 0.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.4 | 3.5 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.4 | 1.3 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.4 | 1.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.4 | 12.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.4 | 24.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.4 | 7.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 4.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.4 | 5.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.4 | 3.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.4 | 11.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.4 | 1.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.4 | 13.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 1.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 2.1 | GO:0016312 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol bisphosphate phosphatase activity(GO:0016312) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.4 | 3.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.4 | 21.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.4 | 0.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.4 | 5.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.4 | 10.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.4 | 2.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 7.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.4 | 1.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 6.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.4 | 4.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.4 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 2.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.4 | 6.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.4 | 2.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.4 | 42.9 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.4 | 5.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.4 | 1.2 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.4 | 9.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.4 | 7.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.4 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 5.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.4 | 0.4 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.4 | 2.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.4 | 7.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 5.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.4 | 1.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.4 | 2.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.4 | 1.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.4 | 3.3 | GO:0008430 | selenium binding(GO:0008430) |
| 0.4 | 10.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.4 | 5.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.4 | 0.7 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 2.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.4 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.4 | 2.2 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 2.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.4 | 23.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.4 | 9.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 2.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.4 | 0.7 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.4 | 56.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.4 | 3.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.4 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.4 | 1.1 | GO:0031737 | CX3C chemokine receptor binding(GO:0031737) |
| 0.4 | 6.7 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 4.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.3 | 4.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.3 | 1.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.3 | 2.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 1.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.3 | 18.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 3.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 1.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.3 | 1.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 1.7 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.3 | 2.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 4.4 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.3 | 1.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.3 | 2.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 3.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.3 | 13.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.3 | 2.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 2.3 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.3 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.3 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.3 | 30.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.3 | 4.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 1.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 2.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 0.3 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.3 | 5.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 5.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 1.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.3 | 4.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.3 | 3.8 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.3 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 15.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.3 | 16.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.3 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.3 | 2.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.3 | 2.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.3 | 2.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.3 | 1.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.3 | 0.9 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.3 | 0.9 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.3 | 1.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.3 | 9.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.3 | 2.4 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.3 | 10.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.3 | 0.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 12.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.3 | 2.7 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.3 | 0.9 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.3 | 1.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 1.8 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.3 | 12.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.3 | 36.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 4.2 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 6.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.3 | 1.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 8.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.3 | 7.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 3.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 0.9 | GO:0016642 | glycine dehydrogenase (decarboxylating) activity(GO:0004375) oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor(GO:0016642) vitamin B6 binding(GO:0070279) pyridoxal binding(GO:0070280) |
| 0.3 | 2.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.3 | 1.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.3 | 3.5 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 2.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 1.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.3 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 14.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.3 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 4.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.3 | 2.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 1.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.3 | 7.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 8.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.3 | 62.4 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.3 | 3.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.3 | 5.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.3 | 8.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.3 | 1.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.3 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.3 | 2.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 6.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.3 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 2.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 1.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.3 | 19.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.3 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 2.4 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.3 | 1.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.3 | 1.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 1.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 10.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 16.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.3 | 5.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.3 | 2.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.3 | 1.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.3 | 8.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.3 | 1.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.3 | 9.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.3 | 3.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.3 | 2.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.3 | 2.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.3 | 0.8 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.3 | 0.8 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.3 | 3.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 8.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 1.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.2 | 0.7 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
| 0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 11.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.2 | 46.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 1.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.2 | 13.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.2 | 15.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.2 | 11.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 4.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 0.7 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.2 | 4.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.2 | 8.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 4.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.2 | 3.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 4.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 0.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 3.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.2 | 1.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.2 | 0.9 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.2 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.2 | 0.9 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 5.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 1.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 1.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 1.5 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 2.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 0.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 0.6 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.8 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.2 | 7.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 8.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.2 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 5.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.2 | 4.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 1.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.2 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.2 | 9.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 33.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.2 | 8.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 5.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.2 | 3.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 0.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.2 | 0.6 | GO:0033791 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity(GO:0033791) |
| 0.2 | 2.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.2 | 1.1 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.2 | 6.5 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 1.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.2 | 0.7 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.2 | 5.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 2.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.2 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.2 | 3.3 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 9.6 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 7.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 12.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 0.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.2 | 0.5 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.2 | 0.5 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.2 | 3.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.2 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.2 | 0.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 5.8 | GO:0003774 | motor activity(GO:0003774) |
| 0.2 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.2 | 2.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 1.0 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.2 | 0.7 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.2 | 11.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 1.7 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.2 | 1.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.2 | 0.5 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.2 | 6.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.8 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.2 | 1.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 34.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 2.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.2 | 0.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 0.2 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.2 | 0.2 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.2 | 1.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.2 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 0.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 6.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 4.6 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 0.6 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 2.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 4.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 2.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 2.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 0.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 1.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.8 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.1 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 1.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 4.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 3.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.8 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.5 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 2.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 1.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.1 | 0.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.3 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 1.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.5 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.1 | 1.0 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 46.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.4 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.1 | 0.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.1 | 0.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.1 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.1 | 0.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.2 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 1.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 35.4 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.3 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.1 | 1.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.1 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 3.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.3 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.1 | 2.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 1.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.1 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.3 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.1 | 0.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
| 0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 8.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.5 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.1 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 0.7 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.1 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 1.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 1.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 5.6 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 4.7 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 13.1 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.1 | 0.2 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.1 | 1.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.0 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.1 | 0.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 0.4 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.1 | 0.3 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 1.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.2 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.1 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 0.2 | GO:0070975 | FHA domain binding(GO:0070975) |
| 0.1 | 0.2 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.1 | 0.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.1 | 0.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.1 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
| 0.1 | 0.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.1 | 0.3 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.2 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
| 0.1 | 0.2 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.1 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.0 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.1 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
| 0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 5.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.1 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 0.5 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.0 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.0 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.0 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 3.9 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.1 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.0 | 0.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.0 | 3.0 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.0 | 0.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.0 | 0.1 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.0 | 0.3 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.0 | 0.1 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.0 | 1.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) RNA strand-exchange activity(GO:0034057) |
| 0.0 | 0.1 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.0 | 0.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.0 | 0.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 8.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 4.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.9 | 19.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.9 | 7.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.9 | 42.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.8 | 10.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.8 | 3.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.7 | 15.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.7 | 14.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.6 | 6.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.6 | 9.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.6 | 20.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 33.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.5 | 38.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.5 | 36.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.5 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.5 | 36.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.5 | 12.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.5 | 4.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.5 | 15.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.5 | 10.1 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.5 | 33.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.4 | 10.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.4 | 19.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 12.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.4 | 29.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.4 | 21.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 16.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.4 | 2.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.4 | 10.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.4 | 105.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.4 | 21.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 5.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.3 | 14.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 8.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.3 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.3 | 2.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 7.6 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.3 | 5.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 7.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 21.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 6.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.3 | 10.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.3 | 3.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.3 | 1.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.3 | 2.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 8.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 9.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 6.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 2.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 12.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.2 | 60.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 3.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 15.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 83.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 25.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 3.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 5.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 2.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 2.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 3.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 9.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 30.7 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 4.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 3.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 2.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 1.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 8.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 2.0 | 61.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.7 | 1.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
| 1.4 | 4.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 1.3 | 26.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 1.3 | 56.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 1.3 | 7.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 1.1 | 67.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 1.1 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 1.1 | 56.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 1.1 | 30.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.1 | 40.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 1.0 | 17.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.0 | 44.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.0 | 25.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.8 | 22.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.8 | 11.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.7 | 19.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.7 | 13.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.7 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.7 | 16.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.6 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.6 | 9.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.6 | 24.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.6 | 10.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.6 | 42.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.6 | 16.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.6 | 34.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.6 | 16.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.6 | 22.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 2.3 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
| 0.6 | 26.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.6 | 14.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.6 | 5.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.6 | 17.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.6 | 27.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.6 | 70.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.6 | 9.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.5 | 9.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 2.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.5 | 8.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 27.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.5 | 1.5 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.5 | 12.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 11.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.5 | 19.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.5 | 33.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.5 | 1.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.5 | 9.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 6.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.5 | 7.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.5 | 15.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.4 | 9.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.4 | 1.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.4 | 7.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 16.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.4 | 5.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.4 | 9.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 3.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 8.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.4 | 6.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.4 | 18.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.4 | 9.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 16.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 5.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.3 | 14.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.3 | 9.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.3 | 3.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 8.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 15.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.3 | 4.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 5.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 7.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.3 | 16.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 11.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 14.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.3 | 29.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.3 | 17.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.3 | 7.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 13.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.3 | 2.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.3 | 7.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 9.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 6.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 5.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.2 | 42.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.2 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 7.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.2 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 7.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 1.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 13.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 8.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 4.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 1.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 9.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 11.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 1.9 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.1 | 2.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 27.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 0.4 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
| 0.1 | 5.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 10.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 3.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 5.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 5.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 3.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 20.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 8.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 2.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 3.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 2.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 22.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 1.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 8.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 0.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 6.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 2.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 0.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.0 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |